Australian antiviral drug development company Island Pharmaceuticals (ASX:ILA) has announced new data that are expected to introduce significant, quantifiable time and cost savings into its clinical program for dengue fever. …
Island Pharmaceuticals says new data leads to ISLA-101 Phase 2 study changes
June 3, 2024 Australian Biotech
Latest Video
New Stories
-
Trump's language on pricing matches Australia's reflex response to PBS criticism
May 13, 2025 - - Latest News -
Health stakeholders welcome the reappointment of Mark Butler
May 12, 2025 - - Latest News -
Pharma stocks rise in response to Trump's 'MFN' executive order
May 12, 2025 - - Latest News -
Lilly touts weight management results in new head-to-head study
May 12, 2025 - - Latest News -
Experienced industry executive appointed chair of Tryptamine Therapeutics
May 12, 2025 - - Australian Biotech -
Monash scientists secure MRFF funding to find new medicines for dementia by 'lighting up' human brain cells
May 12, 2025 - -
Radiopharm Theranostics accelerates 177Lu-RAD204 Phase 1 dose escalation trial
May 12, 2025 - - Australian Biotech